OH2

AXP000089.1 · Oncolytic virus

Platform
HSV-2 (strain HG52, ICP34.5- ICP47-)
Originator
Binhui Biopharmaceutical
Sponsor
Binhui Biopharmaceutical

Names

NameTypeSource
OH2 ambiguouspreferred name, codecurator, ncit
OH2 injectionsynonymctgov
oHSV2hGM-CSFsynonymcurator

Virus

Role
Oncolytic
Family
Orthoherpesviridae
Virus
herpes simplex virus 2 (NCBI Taxonomy 10310)
Strain
HG52
Replication
conditionally replicating
Modifications
ICP34.5 and ICP47 deleted; ICP6 mutated
Transgenes
CSF2
Route
intratumoral, intravesical
Source
evidence

Cross-references

NCI Thesaurus
C172106

Approvals

No regulatory approval recorded.

Clinical trials (14)

TrialTitleStatusPhaseStartPrimary completionEnrolmentConditions
NCT07854522A Study of QL1706 Combined With OH2 Injection in Perioperative Treatment of Stage III Resectable Acral MelanomaNot yet recruitingPhase 42026-102029-0976Acral Melanoma; Melanoma
NCT05954091OH2 Administered by Intratumoral InjectionNot yet recruitingPhase 12025-09-012027-07-0129Solid Tumor
NCT05648006First-line Maintenance of OH2 Injection for Advanced Colorectal CancerTerminatedPhase 22023-10-172024-04-157Advanced Colorectal Carcinoma
NCT05698459OH2 Oncolytic Viral Therapy Via Transcatheter Intraarterial Infusion in Patients with Advanced Liver CancerRecruitingPhase 12023-05-052025-0812Advanced Liver Cancer
NCT05868707OH2 Injection in MelanomaRecruitingPhase 32023-03-082026-03340Melanoma
NCT05232136OH2 Oncolytic Viral Therapy in Non-Muscle-Invasive Bladder CancerUnknownPhase 1/22022-07-112025-0630Non-muscle-invasive Bladder Cancer
NCT05248789OH2 Oncolytic Viral Therapy in Advanced Bladder CancerTerminatedPhase 22022-05-252024-10-284Advanced Bladder Carcinoma
NCT05235074OH2 Oncolytic Viral Therapy in Central Nervous System TumorsCompletedPhase 1/22021-11-162026-07-2340Central Nervous System Tumors
NCT05070221Study of Oncolytic Virus in Combination With HX-008 and Axitinib in Melanoma Patients With Liver MetastasisUnknownPhase 12021-10-012023-10-3130Melanoma Stage IV
NCT05068453Study of Oncolytic Virus in Combination With HX-008 and Radiotherapy in Melanoma Patients With Liver MetastasisUnknownPhase 12021-10-012023-10-3115Melanoma Stage IV
NCT04637698OH2 Oncolytic Viral Therapy in Pancreatic CancerTerminatedPhase 1/22021-02-022023-05-045Pancreatic Cancer
NCT04616443OH2 Injection in Combination With HX008 for Melanoma.RecruitingPhase 1/22020-12-012025-11-3060Melanoma
NCT03866525OH2 Oncolytic Viral Therapy in Solid TumorsRecruitingPhase 1/22019-04-022025-08-30300Gastrointestinal Cancer; Solid Tumor
NCT04386967OH2 Injection in Solid TumorsCompletedPhase 1/22018-11-222026-06-0244Melanoma; Solid Tumor
Unconfirmed matches (1)

Trials that mention one of the names in a weaker way (a code only in the title, a short or ambiguous name). Not counted above.

TrialTitleStatusPhaseStartPrimary completionEnrolmentConditionsMatched by
NCT07382531OH2 Injection in Combination With BS006 Injection for Advanced Solid TumorsRecruitingPhase 1/22023-09-072027-12-3130Solid Tumorname in title: OH2 injection

Recent changes

No changes recorded in its trials yet.

Clinical papers

PubMedTitleJournalYearLinked by
PMID 39915002Oncolytic virus OH2 extends survival in patients with PD-1 pretreated melanoma: phase Ia/Ib trial results and biomarker insights.Journal for immunotherapy of cancer2025cited by trial NCT04386967
PMID 38537773OH2 oncolytic virus: A novel approach to glioblastoma intervention through direct targeting of tumor cells and augmentation of anti-tumor immune responses.Cancer letters2024cited by trial NCT05235074
PMID 34757194cited by trial NCT03866525

Other papers

Preclinical studies, reviews and other papers that name it.

PubMedTitleJournalYearLinked by
PMID 22780924[Construction of a new oncolytic virus oHSV2hGM-CSF and its anti-tumor effects].Zhonghua zhong liu za zhi [Chinese journal of oncology]2012name in title: oHSV2hGM-CSF

Notes

Oncolytic HSV-2 armed with GM-CSF, the most clinically advanced HSV-2-based oncolytic. Dosed intratumorally in solid tumours and melanoma and intravesically in bladder cancer.

How to cite

OH2 (AXP000089.1). The Abstractinator program registry, release 2026-11-17+2c46e992acfc. https://abstractinator.me/registry/AXP000089.html

Something wrong or missing? Suggest a correction (a GitHub issue; please link your evidence). Entry created 2026-11-11, updated 2026-11-11.